Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Raymond_J._Tesi
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
XPro1595
INKmune |
| gptkbp:focusesOn |
oncology
immunotherapy neuroinflammation |
| gptkbp:foundedYear |
2015
|
| gptkbp:headquartersLocation |
gptkb:La_Jolla,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
INmune Bio, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockSymbol |
gptkb:INMB
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.inmunebio.com/
|
| gptkbp:bfsParent |
gptkb:INMB
gptkb:INmune-ALPHA |
| gptkbp:bfsLayer |
8
|